Pfizer profit misses estimates, revenue declines as Lyrica sales tumble
Share:
(Reuters) - Pfizer Inc on Tuesday reported lower-than-expected quarterly profit and a decline in revenue as sales of its off-patent pain treatment Lyrica more than halved, sending its shares down more than 3%.The largest U.S. drugmaker is spinning off its struggling Upjohn unit, which houses off-patent drugs including Lyrica and Viagra, and separated its consumer health business last year to focus on its more profitable drugs.The company's total revenue fell 9% to $12.69 billion in the fourth..